Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Potential Causes of Cystic Fibrosis-Related Diabetes
Lise Coderre, Lyna Debieche, J. R. Plourde, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 21

Showing 21 citing articles:

What the future holds: cystic fibrosis and aging
S E Blankenship, Aaron R. Landis, Emily Harrison Williams, et al.
Frontiers in Medicine (2024) Vol. 10
Open Access | Times Cited: 8
Renewing the fight: A call to action for diabetes and chronic kidney disease
Roberto Pecoits–Filho, Beatriz Yáñez Jiménez, Gloria Ashuntantang, et al.
Diabetes Research and Clinical Practice (2023) Vol. 203, pp. 110902-110902
Closed Access | Times Cited: 9
Cystic fibrosis–related metabolic defects: crosstalk between ion channels and organs
Sunder Sims‐Lucas, Eric S. Goetzman, Thomas R. Kleyman
Journal of Clinical Investigation (2024) Vol. 134, Iss. 13
Open Access | Times Cited: 3
Cystic Fibrosis-Related Diabetes: Clinical approach and knowledge gaps
Bernadette Prentice, Kathryn J. Potter, Adèle Coriati, et al.
Paediatric Respiratory Reviews (2022) Vol. 46, pp. 3-11
Closed Access | Times Cited: 13
Chronic Calcific Pancreatitis and Its Association With Secondary Diabetes Mellitus
G. Bahl, Md Sadique Hussain, Dinesh K. Upadhyay, et al.
Journal of Endocrinology and Metabolism (2023) Vol. 13, Iss. 3, pp. 89-95
Open Access | Times Cited: 6
Oxidative Stress Biomarkers in Cystic Fibrosis and Cystic Fibrosis-Related Diabetes in Children: A Literature Review
Anca Daniela Pinzaru, Cristina Maria Mihai, Tatiana Chisnoiu, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2671-2671
Open Access | Times Cited: 5
Canadian Cystic Fibrosis–related Diabetes Clinical Practice Survey: Analysis of Current Practices and Gaps in Clinical Care
Kathryn J. Potter, Adèle Coriati, Patrick Hicks, et al.
Canadian Journal of Diabetes (2023) Vol. 47, Iss. 3, pp. 263-271.e1
Closed Access | Times Cited: 4
Cystic fibrosis–related diabetes screening at a large pediatric center
Anil K. Chokkalla, P. Tuley, Miray Kurtca, et al.
Laboratory Medicine (2024) Vol. 55, Iss. 5, pp. 580-584
Closed Access | Times Cited: 1
The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis
Lora Stanka Kirigin Biloš, Velimir Altabas, Andrea Vukić Dugac, et al.
Medicina (2024) Vol. 60, Iss. 3, pp. 477-477
Open Access | Times Cited: 1
Beyond insulin: Unraveling the complex interplay of ER stress, oxidative damage, and CFTR modulation in CFRD
Bala Umashankar, Lena Eliasson, Chee Y. Ooi, et al.
Journal of Cystic Fibrosis (2024) Vol. 23, Iss. 5, pp. 842-852
Open Access | Times Cited: 1
Pancreatic KCa3.1 channels in health and disease
Benjamin Soret, Jurek Hense, Simon Lüdtke, et al.
Biological Chemistry (2022) Vol. 404, Iss. 4, pp. 339-353
Closed Access | Times Cited: 4
Acute soluble fibre supplementation has no impact on reducing post-prandial glucose excursions in adults with cystic fibrosis and glucose intolerance
Catherine Lehoux Dubois, Valérie Boudreau, Kathryn J. Potter, et al.
Annales d Endocrinologie (2023) Vol. 84, Iss. 6, pp. 767-772
Closed Access | Times Cited: 1
Changes in glucose tolerance in people with cystic fibrosis after initiation of first‐generation CFTR modulator treatment
Rikke Spragge Ekblond, Bibi Uhre Nielsen, Christine Højte, et al.
Pediatric Pulmonology (2023) Vol. 58, Iss. 9, pp. 2600-2609
Open Access | Times Cited: 1
An Update in Cystic Fibrosis-Related Diabetes in Children and Adolescents
Dana-Teodora Anton-Păduraru, Alina Murgu, Mădălina Andreea Donos, et al.
Children (2023) Vol. 10, Iss. 12, pp. 1879-1879
Open Access | Times Cited: 1
Association between cystic fibrosis transmembrane regulator genotype and clinical outcomes, glucose homeostasis indices and CF-related diabetes risk in adults with CF
Noémie Bélanger, Anne Bonhoure, Tamizan Kherani, et al.
Genetics and Molecular Biology (2024) Vol. 47, Iss. 1
Open Access
Multi-Organ Pathogenesis and Therapeutic Strategies for Cystic Fibrosis
OmotowoIshola Babatunde, Ogonna William David, Richard Ifeanyichukwu Ikwugbado, et al.
Journal of Biosciences and Medicines (2024) Vol. 12, Iss. 05, pp. 312-329
Open Access
Glucagon-like peptide1 receptor agonist treatment of cystic fibrosis-related diabetes complicated by obesity: A cases series and literature review
Ammar Ahmed, Anvitha Ankireddypalli, Tasma Harindhanavudhi, et al.
Journal of Clinical & Translational Endocrinology (2024) Vol. 38, pp. 100375-100375
Open Access
The features of carbohydrate metabolism in children with cystic fi brosis: a 30-year-long history
N. V. Lyabina, О. И. Симонова, И.В. Широкова, et al.
Experimental and Clinical Gastroenterology (2022), Iss. 3, pp. 93-106
Open Access | Times Cited: 1
Cystic fibrosis autoantibody signatures associate with Staphylococcus aureus lung infection or cystic fibrosis-related diabetes
Ruchi Yadav, Quan‐Zhen Li, Hanwen Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access
Recent advances in proteomic-based diagnostics of cystic fibrosis
Refat M. Nimer, Anas M. Abdel Rahman
Expert Review of Proteomics (2023) Vol. 20, Iss. 7-9, pp. 151-169
Closed Access
580 Stem cell–based approaches to elucidate the pathogenesis of cystic fibrosis–related diabetes
I. Khondaker, D. Prasca-Chamorro, Gang Bao
Journal of Cystic Fibrosis (2023) Vol. 22, pp. S308-S309
Open Access
Page 1

Scroll to top